Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2011
Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: potent S1P₁ agonists with in vivo lymphocyte-depleting activity
Mike Frohn, Victor J Cee, Brian A Lanman, et al.
Organic Letters
|
August 8, 2024
Structural Elucidation and Absolute Stereochemistry for Pharma Compounds Using MicroED
Lygia Silva de Moraes, Jessica E Burch, David A Delgadillo, et al.
The Journal of Organic Chemistry
|
March 31, 2012
Synthesis of 4-substituted chlorophthalazines, dihydrobenzoazepinediones, 2-pyrazolylbenzoic acid, and 2-pyrazolylbenzohydrazide via 3-substituted 3-hydroxyisoindolin-1-ones
Hanh Nho Nguyen, Victor J Cee, Holly L Deak, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2015
Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors
Bin Wu, Hui-Ling Wang, Victor J Cee, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 19, 2015
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors
Hui-Ling Wang, Victor J Cee, Frank Chavez, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 20, 2012
Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups
Anthony B Reed, Brian A Lanman, Susana Neira, et al.
Journal of Medicinal Chemistry
|
November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors
Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Cancer Research
|
October 12, 2010
Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines
Marc Payton, Tammy L Bush, Grace Chung, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1
Lewis D Pennington, Kelvin K C Sham, Alexander J Pickrell, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core
Paul E Harrington, Michael D Croghan, Christopher Fotsch, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2011
Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: potent S1P₁ agonists with in vivo lymphocyte-depleting activity
Mike Frohn, Victor J Cee, Brian A Lanman, et al.
Organic Letters
|
August 8, 2024
Structural Elucidation and Absolute Stereochemistry for Pharma Compounds Using MicroED
Lygia Silva de Moraes, Jessica E Burch, David A Delgadillo, et al.
The Journal of Organic Chemistry
|
March 31, 2012
Synthesis of 4-substituted chlorophthalazines, dihydrobenzoazepinediones, 2-pyrazolylbenzoic acid, and 2-pyrazolylbenzohydrazide via 3-substituted 3-hydroxyisoindolin-1-ones
Hanh Nho Nguyen, Victor J Cee, Holly L Deak, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2015
Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors
Bin Wu, Hui-Ling Wang, Victor J Cee, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 19, 2015
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors
Hui-Ling Wang, Victor J Cee, Frank Chavez, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 20, 2012
Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups
Anthony B Reed, Brian A Lanman, Susana Neira, et al.
Journal of Medicinal Chemistry
|
November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors
Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Cancer Research
|
October 12, 2010
Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines
Marc Payton, Tammy L Bush, Grace Chung, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1
Lewis D Pennington, Kelvin K C Sham, Alexander J Pickrell, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core
Paul E Harrington, Michael D Croghan, Christopher Fotsch, et al.
Page
of 4